. Author manuscript; available in PMC: 2019 Oct 18.

Published in final edited form as: Nat Rev Urol. 2019 Mar;16(3):187–200. doi: 10.1038/s41585-018-0135-5

Table 1 |.

Distribution of key clinical variables among MAPP I participants with UCPPS

Sex and total number (n)	Pelvic pain only (n (%))	Any COPC^a (n (%))	Bladder-focused symptoms (n (%))
Male (n = 191)	57 (29.8%)	87 (45.6%)	144 (75.4%)
Female (n = 233)	51 (21.9%)	137 (58.8%)	206 (88.4%)
Male and female (all patients; n = 424)	108 (25.5%)	245 (57.8%)	350 (82.6%)

MAPP I, first phase of the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network; UCPPS, urologic chronic pelvic pain syndrome.

Any chronic overlapping pain condition (COPC) includes chronic fatigue syndrome (CFS), fibromyalgia, irritable bowel syndrome (IBS), temporomandibular joint (TMJ) disorders and migraine and is based on Complex Medical Symptoms Inventory (CMSI) diagnostic criteria.